Pyxis Oncology Inc. (PYXS)
NASDAQ: PYXS
· Real-Time Price · USD
3.35
-0.31 (-8.47%)
At close: Oct 16, 2025, 3:59 PM
3.48
3.88%
After-hours: Oct 16, 2025, 06:25 PM EDT
-8.47% (1D)
Bid | 2.64 |
Market Cap | 207.76M |
Revenue (ttm) | 6.22M |
Net Income (ttm) | -96.29M |
EPS (ttm) | -1.59 |
PE Ratio (ttm) | -2.11 |
Forward PE | -2.76 |
Analyst | Buy |
Dividends | n/a |
Ask | 4.32 |
Volume | 685,120 |
Avg. Volume (20D) | 688,231 |
Open | 3.60 |
Previous Close | 3.66 |
Day's Range | 3.35 - 3.82 |
52-Week Range | 0.83 - 5.39 |
Beta | 1.33 |
Ex-Dividend Date | n/a |
About PYXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PYXS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PYXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-5.83%
Pyxis Oncology shares are trading higher after the...
Unlock content with
Pro Subscription
10 months ago
-45.03%
Pyxis Oncology shares are trading lower after William Blair downgraded the stock from Outperform to Market Perform.